D&D Pharmatech (347850.KQ) Earnings Analysis
D&D Pharmatech (347850.KQ) has no confirmed upcoming earnings date. Trailing P/E -116.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 347850.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 347850.KQ. This page updates as the calendar is published.
347850.KQ earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
347850.KQ valuation and analyst view
| Trailing P/E | -116.60 |
|---|---|
| Trailing EPS | -531.92546 KRW |
| Price / book | 37.45 |
| Dividend yield | 0.00% |
| Market cap | 2584.44B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is D&D Pharmatech (347850.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 347850.KQ. This page updates as the calendar is published.
What is 347850.KQ's current P/E ratio and EPS?
347850.KQ trades at a trailing P/E of -116.60 on trailing EPS of -531.925460045724 KRW.
What do analysts rate 347850.KQ?
347850.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.